Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster

Pfizer has filed a patent lawsuit to block the approval of a generic copy of Vyndamax (tafamidis), the pharma giant’s fast-growing blockbuster heart disease drug.